Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
An overview of which total market fund performed best in 2024, with notes on expense, tracking error, and performance drivers.
28,518 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Washington moves to outlaw noncompete agreements statewide, imposing a 2027 deadline. The sweeping policy reshapes hi...
ServiceNow faced real headwinds long before the AI hype. This article breaks down the root causes, their impact on ma...
As Uber eyes profitability, a multi-year bull case hinges on margin expansion and stronger bookings. This analysis ou...
Unverified reports of a Hormuz Safe platform seeking to settle vessel insurance via Bitcoin raise questions about cry...
Carnival and Norwegian Cruise Line surged in midweek trading, signaling a partial rebound after a brutal month for cr...
Stocks in the AI infrastructure space jump as demand for servers and memory products strengthens. Super Micro Compute...
The York-based TruAdvantage Team unveils a 5,000-square-foot agent support hub as it pushes through a record 2025 and...
Chris Jericho is partnering with Kokopi Koalas to co-create official traits for the Solana-based NFT collection, with...
Forward Industries failed to win any of its three all-stock takeover bids for Solana-related firms, forcing a rethink...
AppLovin is rebounding as AI ad-tech momentum returns, with analysts modeling upside to $600+ as AXON 2 expands and b...
SanDisk stock has surged this quarter, but a fresh price target flags downside risk as memory pricing cools and inves...